Enhanced Delivery of Genetic Testing Processes with GeneFAX™
San Jose, CA, June 18, 2020: OptraHEALTH, a leading data-driven intelligence company, announced new features for its flagship product GeneFAX™: A Digital Navigator for Genetic Testing. GeneFAX™ is trained on Genetic Health empowering organizations to implement workflows for patient triage, pretest education, and post-test counseling and helping physicians recommend appropriate genetic tests.
In addition to already existing modules like ScreeningBOT, KnowledgeBOT, and PhysicianBOT, OptraHEALTHs GeneFAX™ team has just released the CascadeBOT and InsuranceBOT and starting now GeneFAX™ is also available on other social media apps.
Patients that undergo a triage for hereditary cancers or carrier screening and meet the criteria for genetic testing have a question in mind about family member testing. The newly added GeneFAX™ CascadeBOT module proactively allows the patient to inform relevant family members about the benefits of genetic testing. Such a coordinated effort at family genetic testing means fewer patients with diseases. GeneFAX™ CascadeBOT also provides regular notification to patients and their family members about their genetic health.
Genetic tests are increasingly accepted by health insurance plans and patients have questions about how the insurance system works for genetic testing. GeneFAX™ through its InsuranceBOT provides quick answers to such questions but also lets patients find the cost of the test, their eligibility to take the test, and collects data for prior authorization. Healthcare providers receive this complete data ready to send for prior authorization at the click of a button.
GeneFAX™ is now multichannel and all GeneFAX™ BOTs are available on WhatsApp®, this will provide the patient community access to GeneFAX™ from their social media app, too.
“With the addition of GeneFAX™ CascadeBOT and InsuranceBOT, GeneFAX™ provides a solution to all aspects of the genetic testing process, providing a seamless user experience while collecting data for insurance prior-authorization. Providers receive a fully completed dataset for prior authorization submission. And being able to submit it instantly is a big step forward. Organizations and patients are set to gain from reduced denials, thus truly making genetic testing available to everyone.” said Dr. Ashwin Kotwaliwale MD Ph.D., Medical Director, OptraHEALTH.
Using the same engine that drives GeneFAX™, OptraHEALTH recently also launched HealthFAX.AI™ for COVID-19 that includes an array of tools such as contact tracing, self-symptom checker, finding test centers, COVID-19 KnowledgeBOT, etc. Using HealthFAX COVID-19 patients can be assured of information about COVID-19 at their fingertips. The contact tracing module of HealthFAX.AI providers immediate real-time notifications if someone has come nearby of another person having COVID-19.
100 Century Center Court, Suite 410
Media Inquiries Contacts:
Kalyani Rajguru |Business Analyst | OptraHEALTH | email@example.com
OptraHEALTH is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next-generation Artificial Intelligence Platform. OptraHEALTH’s flagship product GeneFAX™ is an AI-powered Knowledge Platform for Genetic Health and is available as a Web Plugin or Mobile application.
Follow us on LinkedIn and Twitter.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enhanced Delivery of Genetic Testing Processes with GeneFAX™ here
News-ID: 2082788 • Views: 179